# Effect of Evolocumab on Vascular Function

Study · id `cardio:ct-nct03626831` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03626831](<https://clinicaltrials.gov/study/NCT03626831>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03626831

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease; Heart failure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT03626831. Randomized; triple masking; primary purpose treatment. Start 2019-04-04 (actual); primary completion 2021-04-15 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT03626831, source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)
- Started: 2019-04-04 (actual) (ClinicalTrials.gov record NCT03626831, source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)
- Primary completion: 2021-04-15 (actual) (ClinicalTrials.gov record NCT03626831, source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)
- Completion: 2021-07-12 (actual) (ClinicalTrials.gov record NCT03626831, source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)
- Countries: Germany (ClinicalTrials.gov record NCT03626831, source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03626831-2023-07-11`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effect of Evolocumab on Vascular Function
- Acronym: EVO
- Condition: Atherosclerotic Cardiovascular Disease
- Intervention (Drug): Evolocumab Prefilled Syringe
- Intervention (Drug): Placebos
- Lead sponsor: University of Erlangen-Nürnberg Medical School
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Evolocumab (`cardio:evolocumab`)
- Registry lists this organization as the lead sponsor: University of Erlangen-Nürnberg Medical School (`cardio:org-university-of-erlangen-nurnberg-medical-school`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Endothelial function in high-risk patients with ezetimibe therapy (`cardio:pubmed-40813220`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: f040e645112af5c44ed221058611a94c37639299c1a008666e88dfb2da640c36
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
